CRISPR and Genome Editing – Products

License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services.

A novel enzyme developed by research scientists at Promega Corporation will virtually eliminate confounding stutter artifacts in forensic DNA analysis.

Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, announced the signature of a long-term commercial supply agreement for CASGEVY® (exagamglogene autotemcel).

Quell Therapeutics Ltd (“Quell” or “the Company”), and eXmoor pharma (“eXmoor”), announce a strategic partnership for the manufacture of multiple autologous engineered CAR-Treg cell therapies in Quell’s pipeline targeting autoimmune diseases.

Kamau to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support its homology-directed repair (HDR) novel gene correction technology.

Refeyn, announces that it has established a new Scientific Advisory Board, chaired by Justin Benesch, Professor of Biophysical Chemistry, Oxford University and co-founder of Refeyn.

Sino Biological is pleased to announce an expansion of its strategic partnership with BioGeometry.

Nona Biosciences, announced that it has entered into a multi-target antibody discovery collaboration with Umoja Biopharma. This collaboration leverages Nona's proprietary fully human heavy chain only antibody (HCAb) technology.

Amy DuRoss, former CEO of Vineti, joins Advisory Board to help Kosten Digital expand its markets and integrate its AI solutions with life science partners.

Stem cell charity Anthony Nolan has announced the opening of the Anthony Nolan Cell Collection Centre in Nottingham, UK.